| Line Item | 2024-03-31 | Y/Y |
|---|---|---|
| Revenue | $4.2M | +118.4% |
| R&D Expense | $5.7M | +28.3% |
| SG&A Expense | $44.4M | -1.7% |
| Operating Income | -$10.1M | +38.5% |
| Pre-tax Income | -$7.5M | +50.1% |
| Income Tax | $1.6M | +27.8% |
| Net Income | -$9.1M | +44.1% |
| EPS (Basic) | -$0.49 | +43.7% |
| EPS (Diluted) | -$0.49 |
| Line Item | 2024-03-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $60.6M | +40.3% |
| Current Assets | $73.0M | +22.8% |
| Total Assets | $324.9M | +16.6% |
| Current Liabilities | $18.0M | -43.7% |
| Total Liabilities | $163.9M | +65.9% |
| Stockholders' Equity | $161.0M | -10.4% |
| Line Item | 2024-03-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $42.0M | +254.1% |
| Capital Expenditures | $307K | -85.6% |
| Investing Cash Flow | $8.1M | +129.8% |
| Financing Cash Flow | -$25.1M | -211.8% |
| Free Cash Flow | $41.7M | +241.9% |
| +43.7% |